search
Back to results

Study and Surgical Treatment of Syringomyelia

Primary Purpose

Syringomyelia

Status
Completed
Phase
Locations
United States
Study Type
Observational
Intervention
Sponsored by
National Institute of Neurological Disorders and Stroke (NINDS)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an observational trial for Syringomyelia focused on measuring Arachnoiditis, Myelography, Intraoperative Ultrasonography, Magnetic Resonance, CSF Pressure, Trauma, Meningitis, Paralysis, Spondylosis, Spinal Syringomyelia, Presyringomyelia, Spinal Cord Edema, Magnetic Resonance Imaging (MRI), Intraoperative Radiation, Ultrasonography

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

INCLUSION CRITERIA: To be eligible to participate in this research study, the subject must: Be 18 years of age or older. Have syringomyelia documented by MRI. Have evidence of neurological deterioration related to syringomyelia or spinal cord tumor. Prior surgery for syringomyelia does not result in exclusion from study. Be able to comprehend the risks of testing and therapy and to give informed consent. EXCLUSION CRITERIA: Subjects will not eligible to participate in this research study if: They are pregnant (because X-rays might injure a fetus). They cannot have an MRI scan as determined by a radiologist. They have a problem with bleeding that cannot be corrected. They are unable to understand the risks of the testing and surgical therapy. Their blood test for HIV (the virus that causes AIDS) is positive, because a positive HIV test would increase your risk of infection from research testing. They have syringomyelia which developed after meningitis, because we have found that laminectomy and duroplasty is ineffective in this setting

Sites / Locations

  • National Institutes of Health Clinical Center, 9000 Rockville Pike

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
February 14, 2001
Last Updated
June 30, 2017
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
search

1. Study Identification

Unique Protocol Identification Number
NCT00011245
Brief Title
Study and Surgical Treatment of Syringomyelia
Official Title
Establishing the Pathophysiology of Primary Spinal Syringomyelia
Study Type
Observational

2. Study Status

Record Verification Date
May 18, 2011
Overall Recruitment Status
Completed
Study Start Date
February 8, 2001 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
May 18, 2011 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)

4. Oversight

5. Study Description

Brief Summary
The goal of this study is to establish the mechanism(s) of progression of primarily spinal syringomyelia (PSS). Our preliminary study of syringomyelia emphasized syringomyelia associated with craniocervical junction abnormalities (CCJAS), such as the Chiari I malformation. This new protocol will expand the scope of our investigation to include primarily spinal syringomyelia (PSS), which is defined as syringomyelia not associated with craniocervical junction abnormalities (CCJAS). Etiologies of primarily spinal syringomyelia include 1) intradural scarring which is post-traumatic, post-inflammatory, or post-operative, 2) intradural-extramedullary masses such as arachnoid cysts or meningiomas, and 3) extramedullary-extradural spinal lesions such as cervical spondylosis or spinal deformity. Our hypothesis is the following: Primarily spinal syringomyelia (PSS), results from obstruction of cerebrospinal fluid (CSF) flow within the spinal subarachnoid space; this obstruction affects spinal CSF dynamics because the spinal subarachnoid space accepts the fluid that is displaced from the intracranial subarachnoid space as the brain expands during cardiac systole; in the case of primarily spinal syringomyelia (PSS), a subarachnoid block effectively shortens the spinal subarachnoid space, reducing CSF compliance and the capacity of the spinal theca to dampen the subarachnoid CSF pressure waves produced by the brain expansion during cardiac systole; the exaggerated spinal subarachnoid pressure waves occur with every heartbeat and act on the spinal cord above the block to drive CSF into the spinal cord and create a syrinx. Presyringomyelia, a recently described state of spinal cord edema associated with progressive myelopathy and obstruction in CSF flow, is a precursor stage to syringomyelia that is consistent with this hypothesis. Because of the importance of this condition to the pathophysiology of syringomyelia, we will also study patients with presyringomyelia in this protocol. After a syrinx is formed, the enlarged subarachnoid pressure waves compress the external surface of the spinal cord, propel the syrinx fluid, and promote syrinx progression. Many neurosurgeons at prominent academic centers routinely use syrinx shunts to treat primarily spinal syringomyelia. This study should provide data that a surgical procedure that opens the spinal subarachnoid space corrects the underlying pathophysiology and resolves the syrinx and that invasion of the spinal cord is unnecessary.
Detailed Description
Objective: The goal of this study is to establish the mechanism(s) of progression of primarily spinal syringomyelia (PSS), the type of syringomyelia that is associated with pathology in the spinal column and not at the craniocervical junction. Our hypothesis is that when a lesion obstructs the spinal subarachnoid space, it shortens the segment of spinal canal that dampens the CSF pressure waves that are produced with each heartbeat and creates enlarged spinal subarachnoid pressure waves that act on the spinal cord above the block to drive CSF into the spinal cord and create a syrinx. After a syrinx is formed, enlarged subarachnoid pressure waves compress the external surface of the spinal cord, propel the syrinx fluid, and promote syrinx progression. Study Population: Subjects will have primary spinal syringomyelia associated with 1) intradural scarring which is post-traumatic, post-inflammatory, or post-operative, 2) intradural-extramedullary masses such as arachnoid cysts or meningiomas, and 3) extramedullary-extradural spinal lesions such as cervical spondylosis or spinal deformity, or 4) an intramedullary tumor. Design: Subjects will have testing before and after standard surgical therapy of syringomyelia. Testing includes measurement of CSF pressure, neurologic examination, CT-myelography, and MR scanning. Results of CSF pressure measurements before surgery will be compared to measurements from normal controls that were previously studied. The effect of surgery on CSF pressure, neurologic examination, CT-myelography, and MRI scans will be evaluated. Outcome Measures: The primary outcome measure is cervical CSF pulse pressure, which is the amplitude of the CSF pressure wave, compared to normal values. Secondary outcomes measures include change in CSF pulse pressure, neurologic examination, CT-myelography, and MRI scans between before and after surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Syringomyelia
Keywords
Arachnoiditis, Myelography, Intraoperative Ultrasonography, Magnetic Resonance, CSF Pressure, Trauma, Meningitis, Paralysis, Spondylosis, Spinal Syringomyelia, Presyringomyelia, Spinal Cord Edema, Magnetic Resonance Imaging (MRI), Intraoperative Radiation, Ultrasonography

7. Study Design

Enrollment
50 (Actual)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
INCLUSION CRITERIA: To be eligible to participate in this research study, the subject must: Be 18 years of age or older. Have syringomyelia documented by MRI. Have evidence of neurological deterioration related to syringomyelia or spinal cord tumor. Prior surgery for syringomyelia does not result in exclusion from study. Be able to comprehend the risks of testing and therapy and to give informed consent. EXCLUSION CRITERIA: Subjects will not eligible to participate in this research study if: They are pregnant (because X-rays might injure a fetus). They cannot have an MRI scan as determined by a radiologist. They have a problem with bleeding that cannot be corrected. They are unable to understand the risks of the testing and surgical therapy. Their blood test for HIV (the virus that causes AIDS) is positive, because a positive HIV test would increase your risk of infection from research testing. They have syringomyelia which developed after meningitis, because we have found that laminectomy and duroplasty is ineffective in this setting
Facility Information:
Facility Name
National Institutes of Health Clinical Center, 9000 Rockville Pike
City
Bethesda
State/Province
Maryland
ZIP/Postal Code
20892
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
10507374
Citation
Heiss JD, Patronas N, DeVroom HL, Shawker T, Ennis R, Kammerer W, Eidsath A, Talbot T, Morris J, Eskioglu E, Oldfield EH. Elucidating the pathophysiology of syringomyelia. J Neurosurg. 1999 Oct;91(4):553-62. doi: 10.3171/jns.1999.91.4.0553.
Results Reference
background
PubMed Identifier
10616064
Citation
Levy EI, Heiss JD, Kent MS, Riedel CJ, Oldfield EH. Spinal cord swelling preceding syrinx development. Case report. J Neurosurg. 2000 Jan;92(1 Suppl):93-7. doi: 10.3171/spi.2000.92.1.0093. Erratum In: J Neurosurg 2000 Apr;92(2 Suppl):249.
Results Reference
background
PubMed Identifier
8271018
Citation
Oldfield EH, Muraszko K, Shawker TH, Patronas NJ. Pathophysiology of syringomyelia associated with Chiari I malformation of the cerebellar tonsils. Implications for diagnosis and treatment. J Neurosurg. 1994 Jan;80(1):3-15. doi: 10.3171/jns.1994.80.1.0003.
Results Reference
background
PubMed Identifier
22958075
Citation
Heiss JD, Snyder K, Peterson MM, Patronas NJ, Butman JA, Smith RK, Devroom HL, Sansur CA, Eskioglu E, Kammerer WA, Oldfield EH. Pathophysiology of primary spinal syringomyelia. J Neurosurg Spine. 2012 Nov;17(5):367-80. doi: 10.3171/2012.8.SPINE111059. Epub 2012 Sep 7.
Results Reference
derived

Learn more about this trial

Study and Surgical Treatment of Syringomyelia

We'll reach out to this number within 24 hrs